{"id":"https://openalex.org/W2961575013","doi":"https://doi.org/10.2337/db19-980-p","title":"980-P: Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes Patients","display_name":"980-P: Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes Patients","alternate_titles":[],"publication_year":2019,"publication_date":"2019-06-01","ids":{"openalex":"https://openalex.org/W2961575013","doi":"https://doi.org/10.2337/db19-980-p","mag":"2961575013"},"language":"en","primary_location":{"id":"doi:10.2337/db19-980-p","doi":"https://doi.org/10.2337/db19-980-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db19-980-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2961575013"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013110210","display_name":"Melissa K. Thomas","orcid":"https://orcid.org/0000-0001-9848-2834","observed_orcids":["https://orcid.org/0000-0001-9848-2834"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MELISSA K. THOMAS","raw_affiliation_strings":["Indianapolis, IN, Austin, TX, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, Austin, TX, Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061113397","display_name":"Amir Nikooienejad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"AMIR NIKOOIENEJAD","raw_affiliation_strings":["Indianapolis, IN, Austin, TX, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, Austin, TX, Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091446537","display_name":"Ross Bray","orcid":"https://orcid.org/0000-0002-6357-9430","observed_orcids":["https://orcid.org/0000-0002-6357-9430"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"ROSS BRAY","raw_affiliation_strings":["Indianapolis, IN, Austin, TX, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, Austin, TX, Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058864022","display_name":"Xuewei Cui","orcid":"https://orcid.org/0000-0001-5181-8740","observed_orcids":["https://orcid.org/0000-0001-5181-8740"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"XUEWEI CUI","raw_affiliation_strings":["Indianapolis, IN, Austin, TX, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, Austin, TX, Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003206993","display_name":"Jonathan Matthew Wilson","orcid":"https://orcid.org/0000-0002-8648-600X","observed_orcids":["https://orcid.org/0000-0002-8648-600X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"JONATHAN M. WILSON","raw_affiliation_strings":["Indianapolis, IN, Austin, TX, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, Austin, TX, Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072130761","display_name":"Kevin L. Duffin","orcid":"https://orcid.org/0000-0002-1656-8982","observed_orcids":["https://orcid.org/0000-0002-1656-8982"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"KEVIN L. DUFFIN","raw_affiliation_strings":["Indianapolis, IN, Austin, TX, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, Austin, TX, Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024563374","display_name":"Zvonko Mili\u010devi\u0107","orcid":"https://orcid.org/0000-0002-6746-901X","observed_orcids":["https://orcid.org/0000-0002-6746-901X","https://orcid.org/0009-0002-8641-023X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"ZVONKO MILICEVIC","raw_affiliation_strings":["Indianapolis, IN, Austin, TX, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, Austin, TX, Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040811419","display_name":"Axel Haupt","orcid":"https://orcid.org/0000-0003-4502-0470","observed_orcids":["https://orcid.org/0000-0003-4502-0470"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"AXEL HAUPT","raw_affiliation_strings":["Indianapolis, IN, Austin, TX, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, Austin, TX, Vienna, Austria","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081732583","display_name":"Deborah A. Robins","orcid":"https://orcid.org/0000-0001-9694-7319","observed_orcids":["https://orcid.org/0000-0001-9694-7319"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"DEBORAH A. ROBINS","raw_affiliation_strings":["Indianapolis, IN, Austin, TX, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, Austin, TX, Vienna, Austria","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9782,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.79642849,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"68","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.7620000243186951},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9620000123977661},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.9290000200271606},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.9959999918937683},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7940000295639038},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":0.8930000066757202},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6079999804496765},{"id":"https://openalex.org/keywords/homa2-ir","display_name":"HOMA2-IR","score":0.7850000262260437},{"id":"https://openalex.org/keywords/homa2-b","display_name":"HOMA2-B","score":0.925000011920929},{"id":"https://openalex.org/keywords/proinsulin-insulin-ratio","display_name":"proinsulin/insulin ratio","score":0.9240000247955322},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.8830000162124634},{"id":"https://openalex.org/keywords/igfbp-1","display_name":"IGFBP-1","score":0.9359999895095825},{"id":"https://openalex.org/keywords/igfbp-2","display_name":"IGFBP-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9200000166893005}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8215116262435913},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7664811611175537},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.7201653718948364},{"id":"https://openalex.org/C90061646","wikidata":"https://www.wikidata.org/wiki/Q426173","display_name":"Proinsulin","level":3,"score":0.7044576406478882},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6871436834335327},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6714977025985718},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6212279200553894},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.498898983001709},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.44636696577072144},{"id":"https://openalex.org/C2776828364","wikidata":"https://www.wikidata.org/wiki/Q1767180","display_name":"Beta cell","level":4,"score":0.42421841621398926},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.42023614048957825},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.29224348068237305},{"id":"https://openalex.org/C165220095","wikidata":"https://www.wikidata.org/wiki/Q207524","display_name":"Islet","level":3,"score":0.13967037200927734}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db19-980-p","doi":"https://doi.org/10.2337/db19-980-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db19-980-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3108676144","https://openalex.org/W4367674317","https://openalex.org/W4281992279","https://openalex.org/W4281635881","https://openalex.org/W7115173337","https://openalex.org/W4281717385","https://openalex.org/W4286311445","https://openalex.org/W4281938962","https://openalex.org/W3173551155","https://openalex.org/W3161292733"],"abstract_inverted_index":{"Tirzepatide":[0],"(TZP),":[1],"a":[2,28,288],"novel":[3],"dual":[4],"GIP":[5],"and":[6,16,47,53,63,108,114,121,125,146,150,160,190,221,230,273,294,310,316,325,333,341,349,357,369,387,392],"GLP-1":[7,23,283],"receptor":[8],"agonist":[9],"(RA),":[10],"showed":[11],"significantly":[12,103,117,134,153,217,256],"greater":[13,289],"glucose":[14,78],"control":[15,79],"weight":[17,169,199,246],"loss":[18,170,200,216],"compared":[19,111,128,143,157,265,279],"to":[20,73,92,172,245],"the":[21,202,208,235,281],"selective":[22,282],"RA":[24,284],"dulaglutide":[25],"(DU)":[26],"in":[27,174,225,299],"26-week,":[29],"randomized,":[30],"double-blind":[31],"Phase":[32],"2b":[33],"study":[34],"of":[35,59,77,83,98,211,223,239,263],"type":[36],"2":[37],"diabetes":[38],"patients.":[39],"TZP":[40,106,122,131,148,228,240,264,286],"doses":[41,262],"tested":[42],"were":[43,66,87,102,255],"1,":[44],"5,":[45,123],"10,":[46,124],"15":[48,109,126,151,229],"mg":[49,110,127,133,152],"versus":[50],"placebo":[51],"(PB)":[52],"DU":[54,120],"1.5":[55],"mg.":[56],"Fasting":[57],"markers":[58,97,249],"beta":[60,84,99,295],"cell":[61,85,100,296],"function":[62,86],"insulin":[64,93,95,136,156,165,175,236,253,292],"sensitivity":[65,137,176,254,293],"analyzed":[67],"by":[68,80,89,105,140,258],"mixed":[69],"model":[70,197],"repeated":[71],"measures":[72],"explore":[74],"differentiated":[75],"mechanisms":[76],"TZP.":[81,90],"Biomarkers":[82],"improved":[88,135,252,300],"Proinsulin":[91],"ratios,":[94],"processing":[96],"stress,":[101],"reduced":[104,164],"10":[107,132,149,231],"with":[112,119,129,144,158,163,177,182,198,227,251,266,280],"PB":[113,145,159,267],"DU.":[115,147],"HOMA2-B":[116],"increased":[118,257],"PB.":[130],"as":[138,201,207],"reflected":[139],"lower":[141],"HOMA2-IR":[142,226],"decreased":[154],"fasting":[155],"DU,":[161,269],"consistent":[162],"resistance.":[166],"To":[167],"evaluate":[168],"contributions":[171],"improvements":[173],"TZP,":[178],"multiple":[179],"linear":[180],"regression":[181],"potential":[183],"confounding":[184],"variables":[185],"age,":[186],"sex,":[187],"metformin":[188],"use,":[189],"baseline":[191],"HbA1c":[192],"was":[193,205],"conducted.":[194],"An":[195],"intercept-free":[196],"only":[203,242],"covariate":[204],"selected":[206],"most":[209],"significant":[210],"all":[212],"possible":[213],"models.":[214],"Weight":[215],"(p<0.004)":[218],"explained":[219],"22%":[220],"28%":[222],"variation":[224],"mg,":[232],"respectively,":[233],"suggesting":[234],"sensitizing":[237],"effects":[238],"are":[241],"partly":[243],"attributable":[244],"loss.":[247],"Multiple":[248],"associated":[250],"one":[259],"or":[260,268],"more":[261],"including":[270],"adiponectin,":[271],"IGFBP1,":[272],"IGFBP2.":[274],"These":[275],"data":[276],"suggest":[277],"that,":[278],"dulaglutide,":[285],"has":[287],"impact":[290],"on":[291],"function,":[297],"resulting":[298],"glycemic":[301],"control.":[302],"Disclosure":[303],"M.K.":[304],"Thomas:":[305],"Employee;":[306,329,337,345,353,365,373,383],"Self;":[307,313,322,330,338,346,354,360,366,374,378,384],"Eli":[308,314,323,331,339,347,355,367,385,390],"Lilly":[309,315,324,332,340,348,356,368,375,379,386,391],"Company.":[311,317,326,334,342,350,358,370,388],"Stock/Shareholder;":[312,359,377],"A.":[318,371],"Nikooienejad:":[319],"Research":[320],"Support;":[321],"R.":[327],"Bray:":[328],"X.":[335],"Cui:":[336],"J.M.":[343],"Wilson:":[344],"K.L.":[351],"Duffin:":[352],"Pfizer":[361],"Inc.":[362],"Z.":[363],"Milicevic:":[364],"Haupt:":[372],"Diabetes.":[376,380],"D.A.":[381],"Robins:":[382],"Funding":[389],"Company":[393]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2961575013","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-07-23T00:00:00"}
